Kae Matsuda-Nagasumi

Suggest Changes
Learn More
BACKGROUND AND PURPOSE TAK-875, a selective GPCR40/free fatty acid receptor 1 agonist, improves glycaemic control by increasing glucose-dependent insulin secretion. Metformin is a first-line drug for(More)
  • 1